论文著作：
1. Yao HJ, Sun L, Li JC, Zhou XF, Li R, Shao RG, Zhang YG, Li L. A novel therapeutic siRNA nanoparticle designed for dual-Targeting CD44 and Gli1 of gastric cancer stem cells. Int J Nanomedicine. 2020, 15: 7013-7034.
2. Yao HJ, Sun L, Liu Y, Jiang S, Pu YZ, Li JC, Zhang YG. Monodistearoylphosphatidylethanolamine-hyaluronic acid functionalization of single-walled carbon nanotubes for targeting intracellular drug delivery to overcome multidrug resistance of cancer cells. Carbon. 2016, 96: 362-376.
3. Yao HJ, Zhang YG, Sun L, Liu Y. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells. Biomaterials. 2014, 35(33): 9208-9223.
4. Yao HJ, Ju RJ, Wang XX, Zhang Y, Li RJ, Yu Y, Zhang L, Lu WL. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery, Biomaterials, 2011, 32(12): 3285-3302.
5. Song WP, Zheng S, Yao HJ, Zhou XF, Li R, Zhang CY, Zhao JY, Wang LW, Shao RG, Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. BMC Ophthalmol. 2020, 20(1): 92.
6. Li R, Zhou XF, Yao HJ, Li L. Four generations of EGFR TKIs associated with different pathogenic mutations in non-small cell lung carcinoma. J Drug Target. 2020, 28(9):861-872.
7. Li JC, Sun L, Liu Y, Yao HJ, Jiang S, Pu YZ, Li YJ, Zhang YG. To reduce premature drug release while ensuring burst intracellular drug release of solid lipid nanoparticle-based drug delivery system with clathrin modification. Nanomedicine.2019, 15(1): 108-118
8. Cao R, Song WP, Ye C, Liu XJ, Li L, Li Y, Yao HJ, Zhou XF, Li L, Shao RG. Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer. Cancer Med. 2019, 8(2):643-655.
姚红娟
北京市
研究领域：
生物医药
研究方向：
肿瘤靶向药物和肿瘤药理学
所在单位：
中国医学科学院北京协和医学院
